Amy Barnett posed a classic Catch-22 scenario: how can she report a problem with a device that might lead to a recall if she doesn’t even know that device is inside her body?
What this illustrates, Barnett said, is a fundamental problem plaguing the Food and Drug Administration’s
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?